Elite 50% OFF Act now – get top investing tools Register Now!

Disc Medicine Inc

Contributing Author

Recent Articles by Disc Medicine Inc

Nov-06	Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update IRON GlobeNewswire
Nov-03	Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting IRON GlobeNewswire
Oct-31	Disc Medicine to Participate in Upcoming Investor Conferences IRON GlobeNewswire
Oct-21	Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants IRON GlobeNewswire
Oct-20	Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants IRON GlobeNewswire
Oct-20	Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones IRON GlobeNewswire
Oct-17	Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week IRON GlobeNewswire
Oct-16	Disc Medicine Announces Receipt of FDA Commissioner's National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP) IRON GlobeNewswire
Sep-30	Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP) IRON GlobeNewswire
Aug-27	Disc Medicine to Participate in Upcoming Investor Conferences IRON GlobeNewswire
Aug-07	Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update IRON GlobeNewswire
Jul-21	Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025 IRON GlobeNewswire
Jul-14	Disc Medicine Appoints Nadim Ahmed to its Board of Directors IRON GlobeNewswire
Jun-12	Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress IRON GlobeNewswire
May-28	Disc Medicine to Participate in Upcoming Investor Conferences IRON GlobeNewswire
May-14	Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress IRON GlobeNewswire
May-13	Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference IRON GlobeNewswire
May-07	Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update IRON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.